Specific protein composition and application method thereof

A protein and composition technology, applied in the field of passive immunization and drugs for preventing tetanus bacillus infection, can solve the problems of poor human tetanus immunoglobulin, not taking into account differences in doses, different injection sites, etc., and saving drug packaging. Cost, good compliance and targeted effects

Pending Publication Date: 2016-07-20
苏文全
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] The above two specific immunoglobulins have the following defects in clinical use: one is that the two specific immunoglobulins need to be injected separately, and the injection sites are different, which makes the operation more troublesome; the other is that the prophylactic injection of human tetanus immunoglobulin The dose is 250IU, which does not take into account the dose difference caused by the difference in weight between children and adults; third, the human tetanus immune globulin is injected intramuscula

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Specific protein composition and application method thereof
  • Specific protein composition and application method thereof
  • Specific protein composition and application method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] 1. Preparation of the present invention

[0027] Liquid A: human rabies immunoglobulin solution prepared according to the three-part process of "Chinese Pharmacopoeia", the human rabies immunoglobulin antibody titer in the solution is 150IU / ml, the concentration of glucose is 20g / L, and the concentration of glycine is 10g / L .

[0028] Liquid B: human tetanus immunoglobulin solution prepared according to the three-part process of "Chinese Pharmacopoeia", the titer of human tetanus immunoglobulin antibody in the solution is 120IU / ml, the concentration of glucose is 20g / L, and the concentration of glycine is 10g / L.

[0029] Specific protein composition: Take 20ml of liquid A and 10ml of liquid B and mix with each other evenly to make human rabies immunoglobulin and human tetanus immunoglobulin compositions. The human rabies immunoglobulin antibody titer in the composition is 100IU / ml , the human tetanus immunoglobulin antibody titer is 40IU / ml, the glucose concentration...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Antibody titeraaaaaaaaaa
Antibody titeraaaaaaaaaa
Potencyaaaaaaaaaa
Login to view more

Abstract

The invention provides a specific protein composition and an application method thereof targeted to passive immunity and clostridium tetani infection prevention of a patient who is bitten or scratched by a mad dog or other mad animals.The specific protein composition and the application method thereof are mainly characterized in that the specific protein composition is formed by mixing human rabies immune globulin and human tetanus immune globulin, wherein the valence of antibodies of the human rabies immune globulin is not lower than 20 IU/ml, the valence of antibodies of the human tetanus immune globulin is not lower than 8 IU/ml, and the value ratio of the valence of antibodies of the human rabies immune globulin to the valence of antibodies of the human tetanus immune globulin is 2.5: 1.The application method comprises the steps of conducting thorough debridement in time; firstly, taking a half of the specific protein composition for conducting subcutaneous infiltration injection on the periphery of the injured part of the patient, and conducting intramuscular injection with the remaining half.The specific protein composition is mainly used for preventing the patient who is bitten or scratched by a mad dog or other mad animals from suffering from rabies and tetanus; the injection amount of the human rabies immune globulin is 10-40 IU/kg, and the injection amount of the human tetanus immune globulin is 4-40 IU/kg.

Description

technical field [0001] The invention relates to a medicine, in particular to a medicine for passive immunization and prevention of tetanus bacillus infection for patients bitten or scratched by rabies or other mad animals and its application method. Background technique [0002] 1. Human Rabies Immunoglobulin [0003] Inoculation of human rabies immunoglobulin and rabies vaccine is an important measure to prevent the onset of severe dog bites. Rabies, commonly known as "mad dog disease", is a zoonotic central nervous system infectious disease caused by rabies virus. The clinical manifestation is hydrophobia. , photophobia, dysphagia, mania, etc. as the main features, is so far the only acute infectious disease in humans with a fatality rate as high as 100%. The "Law of the People's Republic of China on the Prevention and Control of Infectious Diseases" lists rabies as a Class B infectious disease. [0004] This strain is made from the plasma of healthy people immunized wit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/395A61P21/02A61P31/14
CPCA61K2039/507A61K2039/545C07K16/10C07K16/1282A61K39/395
Inventor 苏文全
Owner 苏文全
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products